Pfizer IncPFE
Price$28.12Intrinsic value$21.9622% below price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $63.7B+0.1% YoYTTM through 28 Jun 2026
Net Income $4.3B-46.0% YoYTTM through 28 Jun 2026
Free Cash Flow $11BTTM through 28 Jun 2026

Margins

Current
EBITDA Margin16.9%
Operating Margin6.6%
Net Margin6.8%

Returns

5.1%ROE
2.2%ROA
2.9%ROIC

Balance Sheet Health

Debt / Equity0.74x
Current Ratio1.27x
Net Debt$62.1B
Cash & Equivalents$976M

Quality Metrics

Altman Z-Score2.04
Piotroski F-Score5 / 9
FCF Margin17.2%
Earnings-Beat Rate100.0%

Multi-Year Trend

Revenue
'20'21'22'23'24'25
FY2025: $62.6B
Diluted EPS$0.76TTM
'19'20'21'22'23'24'25
FY2025: $1.36

Dividend

$0.86Per share, FY20263.08%Yield-11.2%5-yr growth

Capital Allocation

Capex Intensity3.8%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.